Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

LY-2183240

Covalent FAAH inhibitor, first presented as an anandamide transport blocker, poorly selective.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₁₇H₁₇N₅O

CAS 874902-19-9

Family
ECS pharmacological toolEnzyme inhibitor
Molar mass
307.35 g/mol

Updated on

In plain terms

LY-2183240 was presented as a blocker of anandamide transport into the cell. A 2006 study showed that it acts mainly by destroying the enzyme that degrades anandamide, and several other enzymes along the way. It is a classic example of a tool whose target was misunderstood; no study in humans was found.

Receptors and activity

Target network

FAAHInhibitorPotent covalent inhibitor by carbamylation of the nucleophilic serine; no numerical value in the abstract (Alexander and Cravatt 2006)
  • Blocks or inhibits

The lower the cited value, the closer the target sits to LY-2183240: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of LY-2183240.

Brain, side view
Body, front view
Blood

FAAHFAAH found in 7 regions of the body

  1. CortexpresentCortical pyramidal neurons1
  2. Basal gangliapresentStriatal neurons1
  3. HypothalamuspresentPresent in hypothalamic nuclei1
  4. CerebellumpresentPurkinje cells and cerebellar layers1
  5. BrainstempresentInferior olivary nuclei1
  6. Adipose tissuepresentExpressed in mature adipocytes2
  7. BonepresentPresent on osteoclasts3

Cited values

  1. FAAHInhibitorno measured value cited

    Potent covalent inhibitor by carbamylation of the nucleophilic serine; no numerical value in the abstract (Alexander and Cravatt 2006)

  2. Captation cellulaire de l'anandamideInhibitorno measured value cited

    Inhibition of the cellular uptake of anandamide (Ortar et al. 2008); it could be due mainly to FAAH inactivation (Alexander and Cravatt 2006); no value taken from the abstracts

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

LY-2183240 illustrates the risk of inferring a mechanism from a tool whose target one thinks one knows. It had been introduced as an inhibitor of the putative anandamide transporter: it disrupted the cellular uptake of this endocannabinoid and promoted analgesia in vivo. Alexander and Cravatt showed in 2006 that it is a potent covalent FAAH inhibitor, which it inactivates by carbamylation of the active-site serine nucleophile; the blockade of uptake may therefore be due primarily to inactivation of FAAH, and their activity-based proteomic screen revealed other brain serine hydrolases that it inhibits, hence the warning about this chemotype. Ortar and colleagues (2008) confirm that it inhibits both cellular uptake and hydrolysis of anandamide; Maione and colleagues (2008) report that, in mice, its antinociceptive effect in the formalin test is antagonised by rimonabant and attribute part of the activity of this tetrazole class to uptake inhibition independent of FAAH. These results are preclinical; no study in humans was found.

History

Source
An entirely synthetic compound with no natural occurrence. It is known as a pharmacological research reagent; no clinical trial or human use was found in the sources consulted.

Origin

Research tool

No biological pathway: LY-2183240 is a synthetic compound of the carbamoyl tetrazole class (heterocyclic ureas), unrelated to the plant cannabinoid pathway.

Classification

Family, origin and source verification

Family

ECS pharmacological tool › Enzyme inhibitor

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

LY-2183240 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

IUPAC name
N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide
Other names
LY2183240 · LY 2183240

Identifiers

Formula
C₁₇H₁₇N₅O
CAS
874902-19-9
InChIKey
GZNIYOXWFCDBBJ-UHFFFAOYSA-N
SMILES
CN(C)C(=O)N1C(=NN=N1)CC2=CC=C(C=C2)C3=CC=CC=C3

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.